 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$2.45 |
$2.50 |
$2.41 |
$2.44 |
11.90K | | 04/19/2024 |
$2.44 |
$2.48 |
$2.42 |
$2.44 |
18.30K | | 04/22/2024 |
$2.35 |
$2.73 |
$2.35 |
$2.65 |
28.00K | | 04/23/2024 |
$2.51 |
$2.63 |
$2.49 |
$2.59 |
7.60K | | 04/24/2024 |
$2.54 |
$2.58 |
$2.45 |
$2.56 |
33.00K |
|
|
| XTL Biopharmaceuticals is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Co.'s existing drug, hCDR1, is a treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. hCDR1 is also Phase II-ready for the treatment of SS. SS is a chronic autoimmune disorder affecting lacrimal and salivary gland function (glandular) but may also affect other organs and systems (extraglandular) such as the kidneys, and gastrointestinal system, among others. | |
|
XTL Biopharmaceuticals (XTLB) has the following price history information. Looking back at XTLB historical stock prices for the last five trading days, on April 18, 2024, XTLB opened at $2.45, traded as high as $2.50 and as low as $2.41, and closed at $2.44. Trading volume was a total of 11.90K shares. On April 19, 2024, XTLB opened at $2.44, traded as high as $2.48 and as low as $2.42, and closed at $2.44. Trading volume was a total of 18.30K shares. On April 22, 2024, XTLB opened at $2.35, traded as high as $2.73 and as low as $2.35, and closed at $2.65. Trading volume was a total of 28.00K shares. On April 23, 2024, XTLB opened at $2.51, traded as high as $2.63 and as low as $2.49, and closed at $2.59. Trading volume was a total of 7.60K shares. On April 24, 2024, XTLB opened at $2.54, traded as high as $2.58 and as low as $2.45, and closed at $2.56. Trading volume was a total of 33.00K shares.
XTLB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into XTL Biopharmaceuticals shares, starting with a $10,000 purchase of XTLB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$17.15 |
|
| End price/share: |
$2.56 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-85.07% |
|
| Average Annual Total Return: |
-17.32% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,493.59 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2024 | $2.44 | | 04/19/2024 | $2.44 | | 04/22/2024 | $2.65 | | 04/23/2024 | $2.59 | | 04/24/2024 | $2.56 |
|
|
